Preoperative intravenous mannitol administration and its rationale before cataract surgery.
Alessandra Di MariaVanessa FerraroGianmaria BaroneAlessandro GaetaPaolo VinciguerraFilippo ConfalonieriPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2024)
The administration of mannitol does not lead to any changes in the ACD and AXL, regardless of whether the eyes are phakic or pseudophakic. However, there is a statistically significant reduction in IOP. Nonetheless, it is important to consider the various side effects associated with mannitol infusion.